Jaguar Health Inc Share Price Nasdaq
Equities
US47010C2017
Biotechnology & Medical Research
Sales 2024 * | 15.11M 1.19B | Sales 2025 * | 22.66M 1.78B | Capitalization | 17.65M 1.39B |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.04B | Net income 2025 * | -21M -1.65B | EV / Sales 2024 * | 1.17 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.78 x |
P/E ratio 2024 * |
-0.67
x | P/E ratio 2025 * |
-0.86
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.62% |
Latest transcript on Jaguar Health Inc
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 30/04/19 |
Chief Tech/Sci/R&D Officer | 60 | 30/04/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
James Bochnowski
CHM | Chairman | 80 | 31/01/14 |
John Micek
BRD | Director/Board Member | 71 | 31/03/16 |
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |